SCHEMBL7253995

SCHEMBL7253995

Nc1ncnc2c1nc(SC1CCCCC1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSPA8 P11142 3/20 0.66
HSPA5 P11021 3/20 0.66
PDE4A P27815 1/20 0.61
PDE4B Q07343 1/20 0.61
PDE4C Q08493 1/20 0.61
PDE4D Q08499 1/20 0.61
RXFP1 Q9HBX9 1/20 0.60
SLC29A1 Q99808 1/20 0.60
GAPDH P04406 2/20 0.58
HSD17B10 Q99714 1/20 0.58
LMNA P02545 1/20 0.57
TP53 P04637 1/20 0.57
HBB P68871 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ADORA3 P0DMS8 2/20 0.55
SLC28A2 O43868 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254002 1.00 HSPA8 (0.66) HSPA8HSPA5PDE4APDE4BPDE4C
SCHEMBL6761778 0.83 HSPA8 (0.73) HSPA8HSPA5RXFP1GAPDHHSD17B10
SCHEMBL6761772 0.83 HSPA8 (0.73) HSPA8HSPA5RXFP1GAPDHHSD17B10
SCHEMBL472569 0.83 HSPA8 (0.72) HSPA8HSPA5RXFP1SLC29A1GAPDH
SCHEMBL472571 0.83 HSPA8 (0.72) HSPA8HSPA5RXFP1SLC29A1GAPDH
SCHEMBL7258733 0.80 HSPA8 (0.68) HSPA8HSPA5RXFP1GAPDHHSD17B10
SCHEMBL1145052 0.80 HSPA8 (1.00) HSPA8HSPA5RXFP1SLC29A1GAPDH
SCHEMBL17412455 0.80 HSPA8 (1.00) HSPA8HSPA5RXFP1SLC29A1GAPDH
SCHEMBL1145049 0.80 HSPA8 (1.00) HSPA8HSPA5RXFP1SLC29A1GAPDH
SCHEMBL13835110 0.79 GAPDH (0.70) HSPA8HSPA5PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051881-A1 SUBSTITUTED PURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS BY SOLID-PHASE COMBINATORIAL STRATEGIES RIBAPHARM INC. (US) 2003-06-26 WO disclosed